# Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU Study

Study · id `cardio:ct-nct03183895` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03183895](<https://clinicaltrials.gov/study/NCT03183895>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03183895

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 132 participants.

## Technical summary

Registry record NCT03183895. Allocation not applicable; no masking; primary purpose treatment. Start 2019-01-15 (actual); primary completion 2026-10-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 132 participants (planned count; ClinicalTrials.gov record NCT03183895, source copy `cardio:ctgov-nct03183895-2025-01-29`, retrieved 2026-10-26)
- Started: 2019-01-15 (actual) (ClinicalTrials.gov record NCT03183895, source copy `cardio:ctgov-nct03183895-2025-01-29`, retrieved 2026-10-26)
- Primary completion: 2026-10-31 (anticipated) (ClinicalTrials.gov record NCT03183895, source copy `cardio:ctgov-nct03183895-2025-01-29`, retrieved 2026-10-26)
- Completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT03183895, source copy `cardio:ctgov-nct03183895-2025-01-29`, retrieved 2026-10-26)
- Countries: Belarus; Belgium; Czechia; France; Italy; Lithuania; Netherlands; Poland; Switzerland; United Kingdom (ClinicalTrials.gov record NCT03183895, source copy `cardio:ctgov-nct03183895-2025-01-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03183895-2025-01-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU Study
- Condition: Heart Failure
- Condition: Cardiomyopathies
- Intervention (Device): Left ventricular restoration
- Lead sponsor: Ancora Heart, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: 8362fbef180ab8c9c669a1985655ca082a654057c4d43f6535a94f7bd74c5cb8
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
